Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2003-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3ec0c5a036c92c14709ee0c8769638a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b340094de97696cb20154931c7c65464 |
publicationDate |
2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004115219-A1 |
titleOfInvention |
Pharmaceutical composition for prophylaxis and therapy of papillomavirus-derived diseases comprising papillomavirus antigen protein and CpG-oligodeoxynucleotide |
abstract |
The present invention relates to a pharmaceutical composition for prophylaxis and therapy of papillomavirus-derived diseases which comprises papillomavirus antigen protein and CpG-oligodeoxynucleotide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7998492-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101554-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7956043-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004266719-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004181045-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7879810-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004131628-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8574599-B1 |
priorityDate |
2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |